121 related articles for article (PubMed ID: 35848632)
1. Diagnostic Accuracy of Centrally Restricted Diffusion Sign in Cerebral Metastatic Disease: Differentiating Radiation Necrosis from Tumor Recurrence.
Puac-Polanco P; Zakhari N; Miller J; McComiskey D; Thornhill RE; Jansen GH; Nair VJ; Nguyen TB
Can Assoc Radiol J; 2023 Feb; 74(1):100-109. PubMed ID: 35848632
[No Abstract] [Full Text] [Related]
2. Diagnostic Accuracy of Centrally Restricted Diffusion in the Differentiation of Treatment-Related Necrosis from Tumor Recurrence in High-Grade Gliomas.
Zakhari N; Taccone MS; Torres C; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Nguyen TB
AJNR Am J Neuroradiol; 2018 Feb; 39(2):260-264. PubMed ID: 29217742
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing Tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI.
Feng A; Yuan P; Huang T; Li L; Lyu J
Acad Radiol; 2022 Sep; 29(9):1320-1331. PubMed ID: 34896001
[TBL] [Abstract][Full Text] [Related]
4. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
[TBL] [Abstract][Full Text] [Related]
5. The centrally restricted diffusion sign on MRI for assessment of radiation necrosis in metastases treated with stereotactic radiosurgery.
Hainc N; Alsafwani N; Gao A; O'Halloran PJ; Kongkham P; Zadeh G; Gutierrez E; Shultz D; Krings T; Alcaide-Leon P
J Neurooncol; 2021 Dec; 155(3):325-333. PubMed ID: 34689307
[TBL] [Abstract][Full Text] [Related]
6. Centrally Reduced Diffusion Sign for Differentiation between Treatment-Related Lesions and Glioma Progression: A Validation Study.
Alcaide-Leon P; Cluceru J; Lupo JM; Yu TJ; Luks TL; Tihan T; Bush NA; Villanueva-Meyer JE
AJNR Am J Neuroradiol; 2020 Nov; 41(11):2049-2054. PubMed ID: 33060101
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of Recurrent Glioblastoma from Delayed Radiation Necrosis by Using Voxel-based Multiparametric Analysis of MR Imaging Data.
Yoon RG; Kim HS; Koh MJ; Shim WH; Jung SC; Kim SJ; Kim JH
Radiology; 2017 Oct; 285(1):206-213. PubMed ID: 28535120
[TBL] [Abstract][Full Text] [Related]
8. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
9. Can diffusion-weighted imaging distinguish between benign and malignant pediatric liver tumors?
Caro-Domínguez P; Gupta AA; Chavhan GB
Pediatr Radiol; 2018 Jan; 48(1):85-93. PubMed ID: 28921384
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of apparent diffusion coefficient in differentiating between high-grade gliomas and brain metastases.
Caravan I; Ciortea CA; Contis A; Lebovici A
Acta Radiol; 2018 May; 59(5):599-605. PubMed ID: 28835111
[TBL] [Abstract][Full Text] [Related]
11. Solid bone tumors of the spine: Diagnostic performance of apparent diffusion coefficient measured using diffusion-weighted MRI using histology as a reference standard.
Pozzi G; Albano D; Messina C; Angileri SA; Al-Mnayyis A; Galbusera F; Luzzati A; Perrucchini G; Scotto G; Parafioriti A; Zerbi A; Sconfienza LM
J Magn Reson Imaging; 2018 Apr; 47(4):1034-1042. PubMed ID: 28755383
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility-weighted imaging provides complementary value to diffusion-weighted imaging in the differentiation between pyogenic brain abscesses, necrotic glioblastomas, and necrotic metastatic brain tumors.
Lai PH; Chung HW; Chang HC; Fu JH; Wang PC; Hsu SH; Hsu SS; Lin HS; Chuang TC
Eur J Radiol; 2019 Aug; 117():56-61. PubMed ID: 31307653
[TBL] [Abstract][Full Text] [Related]
13. Prediction of recurrence in solid nonfunctioning pituitary macroadenomas: additional benefits of diffusion-weighted MR imaging.
Ko CC; Chen TY; Lim SW; Kuo YT; Wu TC; Chen JH
J Neurosurg; 2019 Feb; 132(2):351-359. PubMed ID: 30717054
[TBL] [Abstract][Full Text] [Related]
14. Added Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging.
Hottat NA; Badr DA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
J Magn Reson Imaging; 2022 Jul; 56(1):158-170. PubMed ID: 34797013
[TBL] [Abstract][Full Text] [Related]
15. Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas.
Hojjati M; Badve C; Garg V; Tatsuoka C; Rogers L; Sloan A; Faulhaber P; Ros PR; Wolansky LJ
J Neuroimaging; 2018 Jan; 28(1):118-125. PubMed ID: 28718993
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of apparent diffusion coefficients and enhancement ratios on magnetic resonance imaging in differentiating primary cerebral lymphomas from glioblastoma.
Anwar SSM; Baig MZ; Laghari AA; Mubarak F; Shamim MS; Jilani UA; Khalid MU
Neuroradiol J; 2019 Oct; 32(5):328-334. PubMed ID: 31188064
[TBL] [Abstract][Full Text] [Related]
17. The Role of Apparent Diffusion Coefficient Values in Glioblastoma: Differentiating Tumor Progression Versus Treatment-Related Changes.
Kamali A; Gandhi A; Nunez LC; Lugo AE; Arevalo-Espejo O; Zhu JJ; Esquenazi-Levy Y; Zhang X; Riascos RF
J Comput Assist Tomogr; 2022 Nov-Dec 01; 46(6):923-928. PubMed ID: 36112011
[TBL] [Abstract][Full Text] [Related]
18. Grading Gliomas Capability: Comparison between Visual Assessment and Apparent Diffusion Coefficient (ADC) Value Measurement on Diffusion-Weighted Imaging (DWI).
Phuttharak W; Thammaroj J; Wara-Asawapati S; Panpeng K
Asian Pac J Cancer Prev; 2020 Feb; 21(2):385-390. PubMed ID: 32102515
[TBL] [Abstract][Full Text] [Related]
19. Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy.
Bobek-Billewicz B; Stasik-Pres G; Majchrzak H; Zarudzki L
Folia Neuropathol; 2010; 48(2):81-92. PubMed ID: 20602289
[TBL] [Abstract][Full Text] [Related]
20. Diffusion Weighted Imaging for Differentiating Benign from Malignant Orbital Tumors: Diagnostic Performance of the Apparent Diffusion Coefficient Based on Region of Interest Selection Method.
Xu XQ; Hu H; Su GY; Liu H; Shi HB; Wu FY
Korean J Radiol; 2016; 17(5):650-6. PubMed ID: 27587953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
